Intravesical gemcitabine as bladder‐preserving treatment for BCG unresponsive non‐muscle‐invasive bladder cancer. Results from a single‐arm, open‐label study

BACKGROUND: There is an unmet alternative medical therapy for BCG unresponsive patients. OBJECTIVE: To report efficacy of intravesical gemcitabine in NMIBC patients, who failed a previous course of BCG, or intolerant, and unwilling to undergo radical cystectomy (RC). MATERIAL AND METHODS: This is an...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurle, Rodolfo, Casale, Paolo, Morenghi, Emanuela, Saita, Alberto, Buffi, Nicolòmaria, Lughezzani, Giovanni, Colombo, Piergiuseppe, Contieri, Roberto, Frego, Nicola, Guazzoni, Giorgio, Lazzeri, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988784/
https://www.ncbi.nlm.nih.gov/pubmed/35474942
http://dx.doi.org/10.1002/bco2.28

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988784/
https://www.ncbi.nlm.nih.gov/pubmed/35474942
http://dx.doi.org/10.1002/bco2.28

Ejemplares similares